114 related articles for article (PubMed ID: 29762164)
1. Cervical cancer screening among HIV-infected women in an urban, United States safety-net healthcare system.
Barnes A; Betts AC; Borton EK; Sanders JM; Pruitt SL; Werner C; Bran A; Estelle CD; Balasubramanian BA; Inrig SJ; Halm EA; Skinner CS; Tiro JA
AIDS; 2018 Aug; 32(13):1861-1870. PubMed ID: 29762164
[TBL] [Abstract][Full Text] [Related]
2. Cervical Cancer Screening among Women Receiving Antiretroviral Therapy in a Resource-Limited Environment.
New-Aaron M; Meza JL; Goedert MH; Kibusi SM; Mkhoi ML; Mayengo CD; Charles J; Shabani S; Musil KM; Cheney A; Sumba S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2035-2045. PubMed ID: 32711430
[TBL] [Abstract][Full Text] [Related]
3. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
[TBL] [Abstract][Full Text] [Related]
4. Screening for cervical cancer in HIV-infected women receiving care in the United States.
Stein MD; Cunningham WE; Nakazono T; Turner BJ; Andersen RM; Bozzette SA; Shapiro MF;
J Acquir Immune Defic Syndr; 2001 Aug; 27(5):463-6. PubMed ID: 11511823
[TBL] [Abstract][Full Text] [Related]
5. Cervical screening in HIV-positive women: characteristics of those who default and attitudes towards screening.
Shah S; Montgomery H; Smith C; Madge S; Walker P; Evans H; Johnson M; Sabin C
HIV Med; 2006 Jan; 7(1):46-52. PubMed ID: 16313292
[TBL] [Abstract][Full Text] [Related]
6. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.
Elit L; Saskin R; Raut R; Elliott L; Murphy J; Marrett L
Gynecol Oncol; 2013 Jan; 128(1):95-100. PubMed ID: 23085459
[TBL] [Abstract][Full Text] [Related]
7. Assessment of factors impacting cervical cancer screening among low-income women living with HIV-AIDS.
Ogunwale AN; Coleman MA; Sangi-Haghpeykar H; Valverde I; Montealegre J; Jibaja-Weiss M; Anderson ML
AIDS Care; 2016; 28(4):491-4. PubMed ID: 26493859
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening among HIV-positive women. Retrospective cohort study from a tertiary care HIV clinic.
Leece P; Kendall C; Touchie C; Pottie K; Angel JB; Jaffey J
Can Fam Physician; 2010 Dec; 56(12):e425-31. PubMed ID: 21375064
[TBL] [Abstract][Full Text] [Related]
9. Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town.
Batra P; Kuhn L; Denny L
S Afr Med J; 2010 Jan; 100(1):39-44. PubMed ID: 20429487
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities, Hawassa town, Ethiopia: a cross-sectional study.
Assefa AA; Astawesegn FH; Eshetu B
BMC Health Serv Res; 2019 Nov; 19(1):847. PubMed ID: 31744548
[TBL] [Abstract][Full Text] [Related]
11. Screening for cervical carcinoma in HIV-infected women: Analysis of main risk factors for cervical cytologic abnormalities.
Sansone M; Saccone G; Migliucci A; Saviano R; Capone A; Maruotti GM; Bruzzese D; Martinelli P
J Obstet Gynaecol Res; 2017 Feb; 43(2):352-357. PubMed ID: 28026078
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach.
Robbins HA; Strickler HD; Massad LS; Pierce CB; Darragh TM; Minkoff H; Keller MJ; Fischl M; Palefsky J; Flowers L; Rahangdale L; Milam J; Shrestha S; Colie C; DʼSouza G
AIDS; 2017 Apr; 31(7):1035-1044. PubMed ID: 28323758
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
15. Anal Cancer and Anal Cancer Screening Knowledge, Attitudes, and Perceived Risk Among Women Living With HIV.
Rodriguez SA; Higashi RT; Betts AC; Ortiz C; Tiro JA; Luque AE; Barnes A
J Low Genit Tract Dis; 2021 Jan; 25(1):43-47. PubMed ID: 33149011
[TBL] [Abstract][Full Text] [Related]
16. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
Momberg M; Botha MH; Van der Merwe FH; Moodley J
BMJ Open; 2017 Feb; 7(2):e013914. PubMed ID: 28213603
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
18. Race and ethnic disparities in cervical cancer screening in a safety-net system.
Owusu GA; Eve SB; Cready CM; Koelln K; Trevino F; Urrutia-Rojas X; Baumer J
Matern Child Health J; 2005 Sep; 9(3):285-95. PubMed ID: 16163439
[TBL] [Abstract][Full Text] [Related]
19. Utilization of Pap testing among women living with HIV enrolled in primary care in Baltimore, Maryland: A 10-year longitudinal study, 2005-2014.
Peprah S; Coleman JS; Rositch AF; Vanden Bussche CJ; Moore R; D'Souza G
Papillomavirus Res; 2018 Dec; 6():52-57. PubMed ID: 30420338
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
